Gene amplification as a target for cancer chemotherapy

Related Experiment Video

Updated: Oct 11, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

R M Snapka1

  • 1Department of Radiology, Ohio State University, Columbus 43210.

Oncology Research
|January 1, 1992
PubMed

Insights

Gene amplification, common in cancer cells, can be targeted for chemotherapy. Low-level stress rapidly eliminates amplified genes, offering new treatment strategies for cancer.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Gene amplification is a hallmark of genetic instability in transformed cells, contributing to cancer development and drug resistance.
  • Amplified oncogenes and proto-oncogenes play critical roles in carcinogenesis and tumor progression.
  • Gene amplification is a frequent mechanism underlying resistance to anticancer therapies.

Purpose of the Study:

  • To investigate the potential of targeting gene amplification as a strategy in cancer chemotherapy.
  • To explore the phenomenon of drug-induced loss of amplified genes.
  • To understand how amplified genes contribute to drug resistance and cancer progression.

Main Methods:

  • Cultured cell populations were subjected to low-level cytotoxic stress.
  • The effect of various drugs and differentiating agents on amplified genes was observed.
  • Different types of extrachromosomally amplified genes, including drug resistance genes and proto-oncogenes, were studied.

Main Results:

  • Low-level cytotoxic stress was found to rapidly eliminate amplified genes from cell populations.
  • A variety of drugs and differentiating agents induced rapid loss of unstably amplified genes.
  • This effect was observed across diverse extrachromosomally amplified genes.

Conclusions:

  • Gene amplification represents a potential therapeutic target for cancer chemotherapy.
  • Drug-induced amplified gene loss may contribute to the selective action of existing cancer drugs.
  • Further understanding of this process could lead to novel cancer treatment strategies.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

DNA-FISH Metaphase Spreads to Distinguish Extrachromosomal DNA from Homogeneously Staining Regions in Human Cancer Cell Lines08:21

DNA-FISH Metaphase Spreads to Distinguish Extrachromosomal DNA from Homogeneously Staining Regions in Human Cancer Cell Lines

Published on: August 4, 2026

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...